BioNexus Gene Lab (BGLC) Current Deferred Tax Assets (2021)
BioNexus Gene Lab recorded quarterly Current Deferred Tax Assets of $67606.0 in Q4 2021.
BioNexus Gene Lab's Current Deferred Tax Assets history runs 1 years deep, the most recent figure standing at $67606.0 for Q4 2021.
- In Q4 2021, Current Deferred Tax Assets changed N/A year-over-year to $67606.0; the TTM figure through Dec 2021 stood at $67606.0 (changed N/A YoY), while the FY2021 annual figure was $67606.0, changed N/A from the prior year.
- Current Deferred Tax Assets came in at $67606.0 for Q4 2021 at BioNexus Gene Lab.
- In the past five years, Current Deferred Tax Assets ranged from a high of $67606.0 in Q4 2021 to a low of $67606.0 in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Linde | 230.79 Bn | 226.84 Bn | 4.26 Bn |
| 2 | Chemical & Mining Co Of Chile | 127.66 Bn | 124.93 Bn | 778.60 Mn |
| 3 | Sherwin Williams | 72.51 Bn | 72.30 Bn | 2.78 Bn |
| 4 | Ecolab | 70.96 Bn | 70.34 Bn | 1.85 Bn |
| 5 | Air Products & Chemicals | 62.15 Bn | 63.70 Bn | 987.40 Mn |
| 6 | Ppg Industries | 25.04 Bn | 23.57 Bn | 1.66 Bn |
| 7 | LyondellBasell Industries | 21.62 Bn | 21.73 Bn | 701.00 Mn |
| 8 | Albemarle | 20.26 Bn | 19.42 Bn | 500.97 Mn |
| 9 | DuPont de Nemours | 19.45 Bn | 19.56 Bn | 602.00 Mn |
| 10 | BioNexus Gene Lab | 5.34 Mn | 1.38 Mn | -790.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 67,606.00 |
| Dec 31, 2021 | 67,606.00 |